ANIKAVISC

US serial number:85134268
Application filling date:Sep. 21, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:May 22, 2012
Publication date:Jan. 11, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: pharmaceuticals, namely, sodium hyaluronate solutions for use in surgical applications International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE Basis: 1(a) First Use: Apr. 25, 2011 Use in Commerce: Apr.
Services:pharmaceuticals namely sodium hyaluronate solutions for use in surgical applications
Current owner owner name:Anika Therapeutics, Inc.
Current owner owner address:32 Wiggins Avenue Bedford, MASSACHUSETTS UNITED STATES 01730
Current owner legal entity type:CORPORATION
Current owner state or country:MASSACHUSETTS
Attorney name:Michael J. Bevilacqua
Attorney email:michael.bevilacqua@wilmerhale.com
Attorney docket number:103.343.138
Attorney email authorized:No
Correspondent name address:MICHAEL J. BEVILACQUA WILMER CUTLER PICKERING HALE & DORR LLP 60 STATE ST STE 25 BOSTON, MASSACHUSETTS UNITED STATES 02109-1816
Correspondent phone:617-526-6448
Correspondent email:michael.bevilacqua@wilmerhale.com
Correspondent fax:617-526-5000
Correspondent email authorized ANIKAVISC:Yes

Reviews

Required fields are marked *